Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Sodium Polystyrene Sulfonate
Therapeutic Area : Nephrology
Study Phase : Approved
Sponsor : Not Applicable
Deal Size : Not Applicable
Deal Type : Not Applicable
ANI Pharmaceuticals Announces the Launch of Kionex® Suspension
Details : Kionex (sodium polystyrene sulfonate suspension) is a commercially available therapeutically equivalent to SPS® Suspension. It is indicated for the treatment of patients suffering from hyperkalemia.
Brand Name : Kionex
Molecule Type : Large molecule
Upfront Cash : Not Applicable
May 20, 2024
Lead Product(s) : Sodium Polystyrene Sulfonate
Therapeutic Area : Nephrology
Highest Development Status : Approved
Sponsor : Not Applicable
Deal Size : Not Applicable
Deal Type : Not Applicable
LOOKING FOR A SUPPLIER?